SYNCOM FORMULATIONS (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 ,inter alia, to consider and approve With Reference to Regulation 29(1)(a) of SEBI (LODR) Regulations, 2015 read with SEBI (PIT) Regulations, 2015, we are pleased to inform that 4/2023-24 Meeting of the Board of directors of the Company is scheduled to be held on Wednesday, 8th November 2023 at 11:00 A.M. at the Corporate office of the Company situated at 207, Saket Nagar, near Saket Club, Indore (M.P.) 452018 to consider and approve the following businesses :1.Approval of the Standalone and Consolidated Un-audited Financial Results for the Quarter and half year ended on 30th September, 2023.2.To take on record the Limited Review Report by the Statutory Auditors for Un-audited Financial Results for the Quarter half year ended on 30th September 2023.3.Approval of the Standalone and Consolidated Un-audited Statement of Assets and Liabilities for the half-year ended 30th September 2023.4.Approval of the Standalone and Consolidated Un-audited Statement of Cash Flow for the half-year ended 30th September, 2023.